Discover how NCOA6 loss is associated with aggressive prostate cancer and EGFR overexpression, highlighting potential ...

The new ASTRO guideline is based on a systematic review of evidence and expert opinion and includes recommendations for MHF, ...

At ESMO 2026, experts forecast how RAS inhibitors, new prostate cancer therapies, and IO combinations may reshape pancreatic, ...

Prostate cancer cases jumped by more than 2,000 in a single year amid greater awareness of the disease, new NHS data for ...

A Gisborne-based research institute is launching an MRI-guided treatment for prostate cancer – the first of its kind in ...

Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...

A “life-changing” new approach to treating prostate cancer will be trialled in Tasmania. Urologist Dr Anthony Eaton will use the NanoKnife procedure, already performed interstate, on three patients at ...

Gisborne’s Mātai Medical Research Institute has treated its first patient using a new and minimally invasive MRI-guided transurethral ultrasound ablation service. On Saturday, Mātai opened the Hugh ...

When we think of prostate cancer, we imagine a serious diagnosis that shows up with loud warning signs. But here’s the truth: many of its early symptoms are like quiet whispers that get drowned out by ...

A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take ...

Women can get cancer in the Skene’s glands, sometimes called the “female prostate.” Skene’s gland cancer is very rare, with only about 20 reported cases to date. Treatment for Skene’s gland cancer may ...

The Girona FC joins the campaign "Put on the Mustache," promoted by the Oncolliga Girona Foundation to raise awareness about ...